AKT1 and metabolic dysfunction-associated steatotic liver disease: Concurrently, regulatory molecules such as NUP85 mediate the upregulation of CCR2 expression through the PI3K/AKT signaling pathway, enhancing inflammatory cell migration and further promoting the progression of MASLD.28